News

Members of the Bimeda-Afrivet executive team in South Africa were delighted to participate in this year's St Patrick's Day festival celebrations, held at the Embassy of Ireland in Pretoria.

ImmunIGY Bovine IgG from Bimeda was named winner of the Royal Dairy Innovation Award at Dairy-Tech last week (7 February).

Bimeda is pleased to announce the release of our second Annual Sustainability Report.

A multidisciplinary team of scientists led by Moredun Research Institute has been awarded £1.5M from the Biotechnology and Biological Sciences Research Council (BBSRC) to combat salmon lice in farmed Atlantic salmon through the development of an oral vaccine. This represents a pivotal step towards a sustainable and effective solution to the pervasive challenges posed by sea lice in the aquaculture industry.

Bimeda, Inc. has recently launched BOVitalize™ in the US. BOVitalize is an oral vitamin and mineral supplement for beef and dairy cows, bulls and ruminating calves.

Irish-owned global animal health company Bimeda is pleased to today mark the official opening of its state-of-the-art sterile injectable manufacturing facility in Shijiazhuang, China, with a ceremony attended by Ireland's Ambassador to China, Dr Ann Derwin, representatives of local Chinese government, and Bimeda's senior leadership team, as well as additional representatives from the Irish Embassy, Enterprise Ireland and the IDA.

Bimeda Holdings Chairman, Donal Tierney, Minister for Enterprise, Trade and Employment, Simon Coveney TD, and Professor Helen Roche, interim UCD Vice-President for Research, Innovation and Impact today officially opened a new €4.8 million state-of-the-art facility incorporating the AgTechUCD Innovation Centre and the UCD Bimeda Herd Health Hub at UCD Lyons Farm in Co. Kildare, Ireland.

Bimeda Inc. is pleased to announce that SpectoGard (spectinomycin sulfate) Sterile Solution—which received FDA approval in September of 2022—is now available for veterinarians and cattle producers in the United States. SpectoGard Sterile Solution is the first bioequivalent, generic spectinomycin sulfate injectable solution that is approved for use in cattle for the treatment of bovine respiratory disease (pneumonia) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni.